V2P predicts variant pathogenicity conditioned on disease phenotypes across top-level Human Phenotype Ontology categories. This approach shows promise for phenotype-specific estimation of variant effe...

Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel artificial intelligence tool that not only identifies disease-causing genetic mutations but also predicts the type of disease those mutations may trigger.